<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/">
  <channel>
    <title>DSpace community: 附設醫院眼科部</title>
    <link>http://140.112.114.62/handle/246246/48121</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li resource="http://140.112.114.62/handle/246246/171570" />
        <rdf:li resource="http://140.112.114.62/handle/246246/171565" />
        <rdf:li resource="http://140.112.114.62/handle/246246/171562" />
        <rdf:li resource="http://140.112.114.62/handle/246246/171558" />
      </rdf:Seq>
    </items>
  </channel>
  <textInput>
    <title>The community's search engine</title>
    <description>Search the Channel</description>
    <name>s</name>
    <link>http://140.112.114.62//simple-search</link>
  </textInput>
  <item rdf:about="http://140.112.114.62/handle/246246/171570">
    <title>Lanreotide Treatment in a Patient with Interferon-Associated Graves Ophthalmopathy</title>
    <link>http://140.112.114.62/handle/246246/171570</link>
    <description>title: Lanreotide Treatment in a Patient with Interferon-Associated Graves Ophthalmopathy abstract: Background We report a case of Graves ophthalmopathy (GO) developed after the administration of interferon- for chronic hepatitis C.Methods The GO was treated with lanreotide.Results A 47-year-old female patient presented with euthyroid GO with spontaneous retrobulbar pain, eyelid edema, conjunctival injection and eyelid retraction of the right eye and conjunctival injection of the left eye 6 months after administration of interferon- for chronic hepatitis C. Orbital computed tomography revealed no involvement of extraorbital muscles and no increase in retrobulbar adipose tissue. Only soft tissue was involved. These symptoms subsided after 12 weeks of lanreotide treatment, except right eyelid retraction, which, however, disappeared later during follow-up.Conclusion The use of interferon- may be complicated by GO and lanreotide might be considered for GO if patients cannot accept steroid therapy .
&lt;br&gt;</description>
  </item>
  <item rdf:about="http://140.112.114.62/handle/246246/171565">
    <title>Etiological Diagnosis of Infectious Endophthalmitis --- a Six-Year Review</title>
    <link>http://140.112.114.62/handle/246246/171565</link>
    <description>title: Etiological Diagnosis of Infectious Endophthalmitis --- a Six-Year Review</description>
  </item>
  <item rdf:about="http://140.112.114.62/handle/246246/171562">
    <title>A Case of Dacryocystocele in an Adult</title>
    <link>http://140.112.114.62/handle/246246/171562</link>
    <description>title: A Case of Dacryocystocele in an Adult</description>
  </item>
  <item rdf:about="http://140.112.114.62/handle/246246/171558">
    <title>Non-contact diode laser transscleral cyclophotocoagulation in the treatment of intractable glaucoma: a preliminary report</title>
    <link>http://140.112.114.62/handle/246246/171558</link>
    <description>title: Non-contact diode laser transscleral cyclophotocoagulation in the treatment of intractable glaucoma: a preliminary report</description>
  </item>
</rdf:RDF>

